USPTO 2015–2025 USPTO PatentsView US Corporation

Astrazeneca Pharmaceuticals Lp

USPTO PatentsView assignee record - 13 granted patents across 9 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

The verdict

According to USPTO PatentsView, Astrazeneca ranks #20,777 of 50,000 tracked US assignees by granted-patent volume, with 13 patents across 9 technology areas.

#20,777
of 50,000 US assignees by volume
Top 74%
by Innovation Score (28.2/100)
14.2
avg claims per patent
-92%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20777 · US Corporation #20,777 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 13 grants
  • MID-PACK #20,777/50,000
  • PHOTO-FINISH Asahi Kasei Construc…
  • CPC-NARROW A61K · 9 areas
  • INNOV-THIN 28.2/100
  • CLAIMS-RICH 14.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -92% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Asahi Kasei Construction Materials Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Astrazeneca

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Astrazeneca's Innovation Score is 28.2/100 (top 74% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Astrazeneca's grants concentrate

Astrazeneca Pharmaceuticals Lp is a focused PatentsView assignee: 9 CPC subclasses with 76.9% of grants classified under A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). Peak complete grant year is 2015 (6 grants) versus a trough of 1 in 2017. By volume, Astrazeneca sits between Asahi Kasei Construction Materials Corporation and Aurora Spine, Inc..

Who files at Astrazeneca's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Astrazeneca holds 13 patents at rank #20,785, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Astrazeneca

By rank, the assignees closest to #20,785 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Astrazeneca's primary technology class.

Astrazeneca's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 Top 74% higher than 26% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). This entry sits in this band. 30–40: 15,294 US assignees (31%). Above this entry. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 20152016201720182020 1
USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Astrazeneca Pharmaceuticals Lp patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 6 46.2%
2016 4 30.8%
2017 1 7.7%
2018 1 7.7%
2020 1 7.7%

Where it ranks

Overall rank by patents

#20,777

of 50,000 tracked assignees

Innovation Score

28.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.